New PectaSol-C® Modified Citrus Pectin Study Shows Critical Support for Cardiac Function

New PectaSol-C® Modified Citrus Pectin Study Shows Critical Support for Cardiac Function - ecoNugenics

What is Cardiac Reperfusion and How Does PectaSol Help?

The blockage of blood flow to organs by a cardiac event of any type, can have significant impacts when circulation is reintroduced. Termed “reperfusion,” the return of blood flow may seem like a good thing. However, it can result in severe consequences for organ and tissue function. Interventions that control this process are essential for long-term health.

A new independent study demonstrates that PectaSol Modified Citrus Pectin (MCP) provides critical support in this area, by inhibiting the actions of rogue protein Galectin-3.* Thousands of published studies show that excess Galectin-3 in the body can have severe impacts on critical areas of health. This fast-growing body of data highlights the importance of blocking Galectin-3 as a leading strategy to support our most vital organs and systems.



Formulated by award-winning Integrative Medicine expert and best-selling author, Isaac Eliaz, MD, PectaSol is clinically-proven and backed by over 80 studies and 6 patents. It has been recommended by thousands of doctors for 30 years to support inflammation responses, immune health and detoxification.*

PectaSol: The Only Galectin-3 Blocker

In recent years, PectaSol has become known as the only available agent to block excess Galectin-3. In doing so, this remarkable natural supplement is shown in a growing number of peer-reviewed studies to offer unparalleled support for our most critical areas of health—from cellular behavior to cardiovascular function, and much more.*

This new study, published in July 2019 in Nature’s Scientific Reports, is the first to identify PectaSol’s ability to block Galectin-3 in a model of cardiac reperfusion. Results show that by inhibiting the upstream signaling actions of Galectin-3, PectaSol can maintain healthy cardiovascular function during reperfusion.*

Based in Spain, this specific research group has previously demonstrated in 15 independent, peer-reviewed studies, the benefits of PectaSol in other aspects of cardiovascular function: healthy weight, vascular flexibility, cardiac capacity, and more.*

Their results consistently highlight the ability of PectaSol to halt and reverse the effects of rogue Galectin-3.*

This new study adds to the data, showing that blocking Galectin-3 with PectaSol is a simple yet powerful strategy to maintain healthy cardiac function following a reperfusion event—and demonstrating yet again the importance of PectaSol as a daily natural solution for long-term health.*